BIM — Biomerieux SA Income Statement
0.000.00%
Last trade - 00:00
- €11.76bn
- €11.93bn
- €3.67bn
- 97
- 12
- 47
- 50
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,675 | 3,118 | 3,376 | 3,589 | 3,675 |
Cost of Revenue | |||||
Gross Profit | 1,467 | 1,754 | 2,001 | 2,009 | 2,057 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,304 | 2,566 | 2,591 | 3,002 | 3,239 |
Operating Profit | 371 | 552 | 785 | 587 | 436 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 348 | 524 | 775 | 581 | 437 |
Provision for Income Taxes | |||||
Net Income After Taxes | 270 | 403 | 599 | 441 | 323 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 273 | 404 | 601 | 452 | 358 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 273 | 404 | 601 | 452 | 358 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.3 | 3.41 | 5.05 | 3.82 | 3.03 |
Dividends per Share |